Foraviset Raising $10M for Further Dev of Raviset, a Novel Endometriosis & Menstrual Symptoms Drug
Foraviset, a privately held innovative pharmaceutical company, seeks to raise US$ 10,000,000 over the next 18 months for clinical trials on Raviset. Raviset is a
Israeli Ministry of Health Gives BrainsWay Insurance Coverage for the Depression Treatment
BrainsWay Ltd. (NASDAQ & TASE: BWAY), a world leader in advanced and non-invasive treatment for brain disorders, announced that the Israeli Ministry of Health has
Alpha Tau Treats First Prostate Cancer Patient with Alpha DaRT!
Jerusalem-based Alpha Tau Medical Ltd. (Nasdaq: DRTS) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, has treated its first patient in
Concenter BioPharma is Raising a New Round Through Crowd Funding for Zygosid-50 Diabetic Drug Clinical Trials
Concenter BioPharma is launching a new round of financing using PipelBiZ Crowdfunding Platform, to conduct a clinical trial here in Israel with the new oral
Eximore Launchs Crowdfunding Campaign for Human Clinical Trials for its Slow Release Ophthalmologic Treatments
Eximore is developing a revolutionary nanomedical device that can prevent blindness using its proprietary non-degradable composite-based formulation technology. Eximore has launched a crowdfunding campaign on
Mirror Bio is moving to the new Bio Park in Har Hozvim
Mirror Biologics is building a 1200m² GMP cell production and research facility in Har Hotzvim’s Bio Park. The new facility will produce AlloStim, a patented,
Neteera- 1 of 10 Best 2022 Patient Monitoring Solution Providers According to Insight Care
Neteera was chosen as one of the Best Patient Monitoring Solution Providers by Insight Care for 2022. Neetera Technologies has developed an AI-powered nursing assistant that
VOTIS Subdermal Imaging Technologies Begins Pilot Feasibility Study at Hadassah Med Center
VOTIS Subdermal Imaging Technologies Ltd. has started enrolling the first patients in the feasibility study of its PedCheck™ device at Hadassah Medical Center in Jerusalem,
Oramed Completes Patient Enrollment of its Pivotal Phase 3 Oral Insulin Study
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, has completed patient enrollment for
